Compass Point Keeps Their Buy Rating on Truist Financial (TFC)
Compass Point Keeps Their Buy Rating on Comerica (CMA)
FTAI Aviation (FTAI) Receives a Buy From Compass Point
Compass Point Remains a Buy on Dynex Capital (DX)
RLI (RLI) Gets a Buy From Compass Point
Compass's Robust Growth and Positive Outlook Secure Buy Rating
BTIG Maintains Compass(COMP.US) With Buy Rating, Raises Target Price to $5
Compass Pathways Price Target Announced at $23.00/Share by RBC Capital
RBC Capital Initiates Coverage On Compass Pathways With Outperform Rating, Announces Price Target of $23
RBC Initiates COMPASS Pathways at Outperform, Speculative Risk With $23 Price Target
Compass Point Initiates Bread Financial at Buy With $54 Price Target
Compass Point Sticks to Their Buy Rating for James River Group (JRVR)
Compass Point Downgrades PennantPark Investment to Sell From Neutral, $6.50 Price Target
Compass Analyst Ratings
Compass Point Downgrades MidCap Financial Investment to Neutral From Buy With $16 Price Target
Morgan Stanley Adjusts COMPASS Pathways Price Target to $23 From $30, Maintains Overweight Rating
Compass Therapeutics Analyst Ratings
Compass Point Remains a Buy on HCI Group (HCI)
FTAI Aviation (FTAI) Receives a Buy From Compass Point
Kepler Capital Remains a Hold on Compass (COMP)